A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)
Clinical trial NCT05029895 · COMPLETED
Trial details
- NCT number
- NCT05029895
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-09-29
- Primary completion
- 2025-09-17
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.